跳至主要内容
临床试验/NCT02259049
NCT02259049已完成早期 1 期

The Effects of L-Tyrosine on Non-invasive Ambulatory Blood Pressure and Heart Rate Monitoring in Parkinson's Disease

New York Institute of Technology2 个研究点 分布在 1 个国家目标入组 6 人开始时间: 2014年10月最近更新:
适应症

试验速览

阶段
早期 1 期
状态
已完成
入组人数
6
试验地点
2
主要终点
Blood Pressure

研究概览

简要总结

The investigators are observing the effects 2,000 mg of L-tyrosine will have on 24 hour blood pressure fluctuations in individuals with Parkinson's disease.

详细描述

We will be monitoring 24 hour ambulatory BP and HR in subjects with PD on 3 separate visits. The first visit will be without an intervention to establish a baseline of 24 hour BP fluctuations. One week later the subject will be given either L-tyrosine (2,000 mg) with B6 (10 mg) or a sugar pill. We will monitor 24 hour BP and HR after supplementation. One week later the subject will repeat the same procedures with either supplement or placebo.

This is a total of 3 visits with 24 hour ambulatory BP and HR monitoring.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
Double (Participant, Outcomes Assessor)

入排标准

年龄范围
40 Years 至 84 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • All subjects must have a diagnosis of PD by a licensed neurologist according to the UK Parkinson's Disease Society Brain Bank Clinical Diagnostic Criteria (UKPDBB).(Goetz, 2010) The UKPDBB is a 3 step diagnostic tool which defines inclusion and exclusion criteria for diagnosing PD
  • between 35 and 79 years of age
  • mentally able to participate in the study

排除标准

  • any person who is currently taking amino acid supplements.
  • Any history of myocardial infarction, stent, or CABG
  • Phenylketonurics
  • Untreated hypertension

结局指标

主要结局

Blood Pressure

时间窗: 24 hours

次要结局

  • Heart Rate(24 hours)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Joanne DiFrancisco-Donoghue

Associate Professor

New York Institute of Technology

研究点 (2)

Loading locations...

相似试验